Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CSAG family member 3 (CSAG3) is a protein-coding gene located on chromosome X, associated with drug resistance in cancer cells and the development of a neoplastic phenotype[1][2][7]. It functions in response to xenobiotic compounds and is not part of the major receptor, enzyme, or transporter families but is implicated in resistance to certain chemotherapies and tumor progression[1][3][7]. It is also known as a cancer/testis antigen and may be used as a biomarker for chemoresistance, though it is not considered a direct therapeutic target at this time[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CSAG family member 3 (CSAG3).